HiSeq and Biomek platforms support a complete RNA-Seq solution

High throughput end-to-end RNA-Seq Service from Beckman Coulter Genomics includes customized project design, automated Illumina* TruSeq* RNA-Seq library construction and flexible, multiplexed sequencing on the Illumina HiSeq platform.  Downstream bioinformatics analysis options include primary data analysis, differential gene expression, splice variant analysis, gene fusion identi?cation and rare transcript identi?cation. 

The new automated library construction process uses Illumina TruSeq RNA sample preparation kits in conjunction with Beckman Coulter Life Sciences’ Biomek* liquid handling platforms. Libraries show consistent size distribution and sequencing data is reproducible, showing good correlation with the published industry standard.

Total RNA from multiple species – including mammalian, plant and yeast samples – has been validated using the automated process.  The scalable, high throughput service allows processing from one to hundreds of samples without compromising quality.

“Automated processing of RNA-Seq using the Biomek platform provides high quality data, and accommodates projects from small to large,” said Bernhard Spiess, vice president of sales and marketing, Beckman Coulter Genomics.  “We are very pleased with this enhanced service and the ability to provide scientists with reliable, reproducible results in a timely manner.”

Technical experts in the company’s genomics services group utilize extensive experience to provide highly reliable data.  Typical turnaround time is four to seven weeks after sample receipt.

For more information about this service, please visit www.beckmangenomics.com/rna-seq.

About Beckman Coulter Genomics

Beckman Coulter Genomics, headquartered in Massachusetts, USA, is a leading provider of genomic services serving life science and healthcare businesses as well as academic and government institutions worldwide. 

About Beckman Coulter

Beckman Coulter, Inc., based in California, USA, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 275,000 Beckman Coulter systems operate in both diagnostics and life sciences laboratories on six continents. For more than 75 years, Beckman Coulter products have been making a difference in peoples’ lives by improving the productivity of medical professionals and scientists, supplying critical information for improving patient health and reducing the cost of care. 

more news from Beckman Coulter,